Market research
603811.SHG Zhejiang Cheng Yi Pharmaceutical Co., Ltd
SHG CNY Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 3B
- P/E ratio
- 16.57
- Analyst target
- Not available
- Dividend yield
- 3.3%
- Beta
- 0.13
Profile
Instrument facts
- Exchange
- SHG
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CNE100002YC7
- Market cap
- 3B
- P/E ratio
- 16.57
- Analyst target
- Not available
- Dividend yield
- 3.3%
- Beta
- 0.13
About
About Zhejiang Cheng Yi Pharmaceutical Co., Ltd
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. engages in the research, development, production, and sales of formulations and active pharmaceutical ingredients in China and internationally. The company offers glucosamine hydrochloride raw materials and preparations, gastrodin raw materials, ribavirin preparations raw materials, and sulfur dioxide raw materials. It also provides injections, food, capsules, tablets, traditional Chinese medicines, preparations, and intermediates; and joint-related drugs, diuretics and antihypertensive drugs, antiviral drugs, antitumor drugs, vitamins, and sedative and brain-boosting drugs, as well as other health products and medical instruments. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is based in Shanghai, China.
Research context
Zhejiang Cheng Yi Pharmaceutical Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 603811.SHG discussion.
5 years, 6 months ago
Zhejiang Cheng Yi Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 2.0% above its 200 day moving average.
From a valuation standpoint, the stock is 21.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.6.
Zhejiang Cheng Yi Pharmaceutical Co., Ltd's total revenue rose by 13.7% to $182M since the same quarter in the previous year.
Its net income has increased by 27.8% to $39M since the same quarter in the previous year.
Finally, its free cash flow fell by 133.6% to $-10M since the same quarter in the previous year.
Based on the above factors, Zhejiang Cheng Yi Pharmaceutical Co., Ltd gets an overall score of 4/5.